Dapagliflozin Linked to Preserved HRV During GLP-1 RA Therapy Tags SGLT-2 Inhibitor Read more about Dapagliflozin Linked to Preserved HRV During GLP-1 RA Therapy
Dapagliflozin-Linagliptin Combination Improved TIR in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about Dapagliflozin-Linagliptin Combination Improved TIR in T2DM
SGLT2 Inhibitors Show No Increased Cancer Risk Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Show No Increased Cancer Risk
ACC.26: AF Rates Were Lower Among GLP-1 Users With Advanced CKD Tags Atrial Fibrillation SGLT-2 Inhibitor Read more about ACC.26: AF Rates Were Lower Among GLP-1 Users With Advanced CKD
AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin
AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin
Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy Tags SGLT-2 Inhibitor Read more about Adolescent Perspectives Highlight Low Burden With SGLT2i Adjunct Therapy
Best Drug for GDM? Outcomes Differ Across Classes Tags Sulphonylureas GLP-1 agonists Biguanide SGLT-2 Inhibitor Read more about Best Drug for GDM? Outcomes Differ Across Classes
ACC 2026: SGLT2 Inhibitors Reduce POAF and AKI in Cardiac Procedures Tags Atrial Fibrillation Diabetic ketoacidosis SGLT-2 Inhibitor Read more about ACC 2026: SGLT2 Inhibitors Reduce POAF and AKI in Cardiac Procedures
SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation Tags hBA1c SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation